Monday, 19 January 2009

Nice Guidance Not

From the Times today

She is also among the one in five sufferers — mostly women — for whom the most common drug, alendronate, is not suitable, meaning that she is prescribed the more costly strontium ranelate. But under draft guidance from NICE, she said, “my doctor would be unable to prescribe an appropriate medication until I had fractured a bone and my bone density had got considerably worse.

“This seems like madness. It's going to cost the NHS a lot more than the treatment costs if people break their bones.”

No comments: